FYERS
Dr. Reddy's Laboratories1162.00
+7.00 (+0.61%)

Dr. Reddy's Laboratories Share Price

1162.00+7.00 (+0.61%)
-7.94% past 1 Year

News

Regulator plans clearer synthetic versus biological drug labelling norms for DRREDDY

Equity
DRREDDY
2 Sept 2026

Dr Reddys Laboratories sees Rs 76.02 crore block trade on BSE

Equity
DRREDDY
27 Aug 2026

India drafts uniform semaglutide manufacturing and testing standards for pharma

Equity
DRREDDY
24 Aug 2026

HC cancels Razenta Pharma’s Daplogin trademark following Dr Reddy’s plea

Equity
DRREDDY
20 Aug 2026

Dr. Reddys Laboratories sees Rs 48.95 Crores NSE block trade

Equity
DRREDDY
10 Aug 2026

Dr. Reddys launches first generic Sugammadex injection in the US market

Equity
DRREDDY
4 Aug 2026

Dr. Reddy’s gets US FDA approval for rituximab biosimilar

Equity
DRREDDY
1 Aug 2026

Dr Reddy'S sees improved Q3, Q4 after resolving semaglutide issues

Equity
DRREDDY
30 Jul 2026

Dr Reddy's gets Thai FDA approval for Nuzolvance zolifloxacin

Equity
DRREDDY
27 Jul 2026

Dr Reddy's sees Rs 24.06 crores NSE block trade at set price level

Equity
DRREDDY
24 Jul 2026

Dr Reddy's Laboratories plans 27 US product launches this year

Equity
DRREDDY
23 Jul 2026

Dr Reddys biologics unit targets profitability with US abatacept launch

Equity
DRREDDY
23 Jul 2026

Dr Reddy’s trims capex guidance, focuses on biosimilars and peptides investments

Equity
DRREDDY
23 Jul 2026

Dr Reddy's Laboratories commentary on normalized full-year effective tax rate guidance

Equity
DRREDDY
23 Jul 2026

Dr Reddy'S Labs guides higher long-term R&D spend at 7 to 8 percent of revenues

Equity
DRREDDY
23 Jul 2026

Dr Reddys plans semaglutide commercial supply restart by November

Equity
DRREDDY
23 Jul 2026

Dr Reddy'S reiterates 20 percent EBITDA margin guidance, eyes upside with semaglutide

Equity
DRREDDY
23 Jul 2026

Jefferies retains Underperform on Dr. Reddy's after sharp Q1 margin miss

Equity
DRREDDY
23 Jul 2026

JPMORGAN retains underweight on Dr. Reddy'S, trims profitability outlook

Equity
DRREDDY
23 Jul 2026

CLSA maintains Hold on Dr. Reddy'S, flags margin headwinds from GSEMAGLUTIDE, freight

Equity
DRREDDY
23 Jul 2026

Dr. Reddy's Laboratories Ltd Share Price Today

The Dr. Reddy's Laboratories Ltd share price today is ₹1,162.00. During the trading session, the Dr. Reddy's Laboratories Ltd share price opened at ₹1,162.00 and recorded an intraday high of ₹1,164.30 and a low of ₹1,155.80. Last closing price was ₹1,156.50. Over the past 52 weeks, the Dr. Reddy's Laboratories Ltd share price has ranged between ₹1,101.00 and ₹1,414.90. The current Dr. Reddy's Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.